Fineline Cube

Follow:
14437 Articles
Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study
CompanyDeals

Shanghai CureGene Completes Series B+ Financing to Advance CG-0255 Study

Regeneron Wins Auction for 23andMe's Core Business Units
CompanyDeals

Regeneron Wins Auction for 23andMe’s Core Business Units

GSK's Blenrep Receives Marketing Approval in Japan for Multiple Myeloma
CompanyDrug

GSK’s Blenrep Receives Marketing Approval in Japan for Multiple Myeloma

Accurate Biotechnology Secures RMB 100M in Series B Funding for Organoid Technology
CompanyDeals

Accurate Biotechnology Secures RMB 100M in Series B Funding for Organoid Technology

Hainan Shuangcheng's Generic Eptifibatide Gains TGA Marketing Approval in Australia
CompanyDrug

Hainan Shuangcheng’s Generic Eptifibatide Gains TGA Marketing Approval in Australia

Stryker's OptaBlate BVN System Gains FDA 510(k) Clearance
CompanyMedical Device

Stryker’s OptaBlate BVN System Gains FDA 510(k) Clearance

Sirius Therapeutics Partners with CRISPR Therapeutics to Develop SRSD107 for Thrombosis
CompanyDeals

Sirius Therapeutics Partners with CRISPR Therapeutics to Develop SRSD107 for Thrombosis

Zai Lab's ZL-1310 Receives FDA Fast Track Designation for SCLC
CompanyDrug

Zai Lab’s ZL-1310 Receives FDA Fast Track Designation for SCLC

Porton and Hualong Biological Partner to Advance MATC Therapy
CompanyDeals

Porton and Hualong Biological Partner to Advance MATC Therapy

AB Science Secures Chinese Patent for Masitinib in COVID-19 Treatment
CompanyDrug

AB Science Secures Chinese Patent for Masitinib in COVID-19 Treatment

4B Technologies Gains NMPA Approval for ALS Drug 4B02-01 Clinical Trials
CompanyDrug

4B Technologies Gains NMPA Approval for ALS Drug 4B02-01 Clinical Trials

Pfizer Licenses 3SBio's Bispecific Antibody SSGJ-707 in Global Deal Excluding China
CompanyDeals

Pfizer Licenses 3SBio’s Bispecific Antibody SSGJ-707 in Global Deal Excluding China